TET2 and acute myeloid leukemia: Patient 9 presented with AML characterized by trisomy 8, mosaicism, 47, XY, +8 [14]/46, XY [6], and BCOR, NRAS, SF3B1, TET2, DDX41, ETV6, and PDGFRA mutations.